Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis — Stella

Home/Idiopathic Gastroparesis/

View on ClinicalTrials.gov

Recruiting

Back to Idiopathic Gastroparesis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

Belgium

Vanda Investigational Site, Leuven

Vanda Investigational Site, Liège

Germany

Vanda Investigational Site, Leipzig

Key details

Phase

Large-scale testing

Sponsor

Vanda Pharmaceuticals

Enrollment target

~100 participants

Started

January 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.